[
    [
        {
            "time": "",
            "original_text": "白雲山(00874)：頭孢丙烯分散片已通過仿製藥質量和療效一致性評價",
            "features": {
                "keywords": [
                    "白雲山",
                    "頭孢丙烯分散片",
                    "仿製藥",
                    "一致性評價"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山(00874)：頭孢丙烯分散片已通過仿製藥質量和療效一致性評價",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-26",
            "original_text": "白雲山(00874.HK)10月26日董事會審議及批准三季度業績",
            "features": {
                "keywords": [
                    "白雲山",
                    "董事會",
                    "三季度業績"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "白雲山(00874.HK)10月26日董事會審議及批准三季度業績",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "白雲山：藥品頭孢丙烯分散片通過仿製藥一致性評價",
            "features": {
                "keywords": [
                    "白雲山",
                    "頭孢丙烯分散片",
                    "仿製藥",
                    "一致性評價"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫藥"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "白雲山：藥品頭孢丙烯分散片通過仿製藥一致性評價",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]